IP Library › Granted Patent US 8,912,185
Granted Patent B2
US 8,912,185 · App. 13/961,019 · Granted Dec 16, 2014

Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents

Inventors: Vladimir Evgenievich Nebolsin (Moscow, RU); Dmitry Sergeevich Blinov (Saransk, RU); Vladimir Pavlovich Balashov (Saransk, RU); Tatyana Alexandrovna Kromova (Kaluga, RU); Galina Alexandrovna Zheltukhina (Moscow, RU)
Assignee: Obschestvo S Ogranichennoi Otvetstvennostyu “Pharmenterprises”
C07D295/13C07D207/09C07D209/20A61K31/4172C07D333/20A61K31/405C07D233/64C07D213/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,912,185
App. No.
13/961,019
Granted
Dec 16, 2014
Kind
B2
Abstract

The invention relates to the use of glutaric acid derivatives of general formula (I), which are disclosed in the invention description, as anti-arrhythmic agents.

Claims (2)

1. A method of treating arrhythymia in a mammal in need thereof, comprising administering to the mammal an effective amount of a compound of formula (I):

or a pharmaceutically acceptable salt thereof.

Priority Claims (1)
RU 2008110644 · Mar 19, 2008 · national
Continuity (2)
Division 12922958
Related Publication 20130324540A1 · Dec 5, 2013